In vivo characterization of [123I]-2-Iodo-L-Phenylalanine in growing R1M rabdomyosarcoma bearing athymic mice as a potential tumour tracer for SPECT

In vivo characterization of [123I]-2-Iodo-L-Phenylalanine in growing R1M rabdomyosarcoma bearing athymic mice as a potential tumour tracer for SPECT

Dettagli Bibliografici
Autori principali:	Kersemans, V, Cornelissen, B, Kersemans, K, Achten, E, Dierckx, R, Mertens, J, Slegers, G
Natura:	Conference item
Pubblicazione:	2004

Documenti analoghi

In vivo evaluation of [I-123]-2-Iodo-D-Phenylalanine in tumour inoculated athymic mice by means of SPECT as a potential diagnostic and radionuclide therapy tool.
di: Kersemans, V, et al.
Pubblicazione: (2004)

In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
di: Kersemans, V, et al.
Pubblicazione: (2005)

Detection of various tumour types in athymic mice with [123I]-2-Iodo-L-Phenylalanine and planar gamma camera acquisition
di: Kersemans, V, et al.
Pubblicazione: (2004)

In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
di: Kersemans, V, et al.
Pubblicazione: (2005)

Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
di: Kersemans, V, et al.
Pubblicazione: (2006)

123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice.
di: Kersemans, V, et al.
Pubblicazione: (2006)

123I-EGF uptake in tumours predicts long-term farnesyltransferase therapy outcome in athymic mice
di: Cornelissen, B, et al.
Pubblicazione: (2004)

Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.
di: Kersemans, V, et al.
Pubblicazione: (2006)

Use of [123I]-2-iodo-L-phenylalanine as a tumor imaging agent in two dogs with synovial cell sarcoma.
di: Peremans, K, et al.
Pubblicazione: (2007)

A rapid in vivo diagnostical assay to assess the effect of a farnesyl transferase inhibitor on lovo cells using I-123-hEGF
di: Cornelissen, B, et al.
Pubblicazione: (2003)

123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction
di: Cornelissen, B, et al.
Pubblicazione: (2004)

Rabdomyosarcoma of the biliary tree
di: E Balkan, et al.
Pubblicazione: (1999-04-01)

Radiosynthesis and in vivo evaluation of 123I-rTIMP-2 as potential SPECT tumour imaging agent
di: Oltenfreiter, R, et al.
Pubblicazione: (2004)

Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice.
di: Cornelissen, B, et al.
Pubblicazione: (2005)

In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker.
di: Cornelissen, B, et al.
Pubblicazione: (2005)

Targeting the tumour: Cell penetrating peptides for molecular imaging and radiotherapy
di: Kersemans, V, et al.
Pubblicazione: (2010)

Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
di: Bart Cornelissen, et al.
Pubblicazione: (2010-03-01)

In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy.
di: Cornelissen, B, et al.
Pubblicazione: (2005)

Exceptional case of a hemangioma-like rabdomyosarcoma in the hand's palm
di: Hassnae Tkak, MD, et al.
Pubblicazione: (2024-08-01)

Influence of farnesyl transferase inhibitor treatment on epidermal growth factor receptor status.
di: Cornelissen, B, et al.
Pubblicazione: (2004)

Synthesis of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno[3,4-c]pyridin-5-one, a potential dopamine D4 ligand for SPECT studies
di: Staelens, L, et al.
Pubblicazione: (2005)

A model system to explore the detection limits of antibody-based immuno-SPECT imaging of exclusively intranuclear epitopes
di: Veal, M, et al.
Pubblicazione: (2021)

Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.
di: Cornelissen, B, et al.
Pubblicazione: (2005)

Cell penetrating peptides for in vivo molecular imaging applications.
di: Kersemans, V, et al.
Pubblicazione: (2008)

Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors.
di: Cornelissen, B, et al.
Pubblicazione: (2013)

Immuno-imaging of ICAM-1 in tumours by SPECT
di: Mosley, M, et al.
Pubblicazione: (2020)

Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer
di: Mosley, M, et al.
Pubblicazione: (2015)

Biodistribution and nuclear import of 111In-labeled HIV-1 tat peptide immunoconjugates after intravenous or intratumoural injection in tumour-bearing mice
di: Cornelissen, B, et al.
Pubblicazione: (2006)

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
di: McLarty, K, et al.
Pubblicazione: (2009)

SPECT imaging and biodistribution studies of 111In-EGF-Au-PEG nanoparticles in vivo
di: Song, L, et al.
Pubblicazione: (2016)

Micro-CT for anatomic referencing in PET and SPECT: radiation dose, biologic damage, and image quality.
di: Kersemans, V, et al.
Pubblicazione: (2011)

Radiolabeled cCPE peptides for SPECT imaging of claudin-4 overexpression in pancreatic cancer
di: Baguna-Torres, J, et al.
Pubblicazione: (2020)

A carbon-fiber sheet resistor for MR-, CT-, SPECT-, and PET-compatible temperature maintenance in small animals
di: Kersemans, V, et al.
Pubblicazione: (2019)

Dual-isotope imaging reveals inter-individual differences in passive uptake of radiolabelled antibodies in tumours
di: Knight, J, et al.
Pubblicazione: (2018)

Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
di: McLarty, K, et al.
Pubblicazione: (2009)

Cardiac Iodine-123-Meta-Iodo-Benzylguanidine Uptake in Carotid Sinus Hypersensitivity.
di: Maw Pin Tan, et al.
Pubblicazione: (2015-01-01)

Diagnostic Efficacy of <sup>123</sup>Iodo-Metaiodobenzylguanidine SPECT/CT in Cardiac vs. Neurological Diseases: A Comparative Study of Arrhythmogenic Right Ventricular Cardiomyopathy and α-Synucleinopathies
di: Johannes M. Hagen, et al.
Pubblicazione: (2024-12-01)

Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours
di: Knight, J, et al.
Pubblicazione: (2019)

Protocols for Dual Tracer PET/SPECT Preclinical Imaging
di: Julia E. Blower, et al.
Pubblicazione: (2020-05-01)

SPECT/CT for tumour imaging
di: Fettich Jure, et al.
Pubblicazione: (2012-01-01)